General

NEIMETH APPOINTS NEW MD/CEO

The Board of Neimeth International Pharmaceuticals Plc has appointed Pharm. Matthew Azoji as the new Managing Director/CEO of the company, which was ratified by the shareholders during the 60th Annual General Meeting of the company held on February 6, 2019 in Lagos.
Pharm. Azoji graduated from the Obafemi Awolowo University, […]

Read more...

World Malaria Day

Malaria is a preventable and treatable infectious disease transmitted by Anopheles mosquitoes that have been infected by a parasite; Plasmodium vivax, P. ovale, P. malariae or P. falciparum. Malaria occurs when there is a bite from the female Anopheles mosquito on humans, thereby transmitting the Plasmodium. The parasite enters […]

Read more...

Invitation to Tender

Neimeth International Pharmaceuticals Plc., is in need of a complete liquid filling and packaging line as part of its expansion drive. Details of the requirement for the proposed liquid filling line are as below:
Liquid Line Requirements:

Washing
Linear Filling
Capping
Labelling
Along with turntables & conveying equipment

SPACE AVAILABLE FOR LINE: 65 FT. x 6 […]

Read more...

WAR AGAINST HYPERTENSION AT ENUGU

Ituku Community of Enugu State on Monday 8th, June 2015 witnessed a large turnout of indigenes who participated in the free Mass Screening and Hypertension Management, courtesy Neimeth International Pharmaceuticals Plc. The event which took place at the Central School had about 25 (Twenty-Five) medical professionals in attendance, led […]

Read more...

Neimeth Launches Co- Amoxiclav – Anti-Biotic

Neimeth International Pharmaceuticals Plc recently increased her Portfolio of diverse therapeutic entities with the introduction of Co- Amoxiclav, a potent antibiotic.
Co-Amoxiclav is a combination of Amoxicillin Trihydrate and Clavulanate Potassium.
Amoxicillin and Clavulanate are indicated for the short term treatment of common bacterial infections such as, Upper Respiratory Tract Infections […]

Read more...